Amiodarone for long-term management of patients with hypertrophic cardiomyopathy

scientific article published on 01 October 1984

Amiodarone for long-term management of patients with hypertrophic cardiomyopathy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-9149(84)80212-X
P698PubMed publication ID6541429

P2093author name stringW J McKenna
L Harris
J F Goodwin
D M Krikler
C M Oakley
E Rowland
A Kleinebenne
P2860cites workAdverse reactions during treatment with amiodarone hydrochlorideQ28366567
Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathyQ33151976
Syncope in hypertrophic cardiomyopathyQ33173222
Clinical electrophysiological effects of propranolol on normal sinus node functionQ36765608
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosisQ36782521
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatmentQ36782571
High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestionQ37173248
The frontiers of cardiomyopathyQ40086997
Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leafletQ40280355
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmiasQ41318052
Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmiasQ42254976
Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective studyQ44022316
The electrophysiology of propranolol in man.Q53890283
Side effects of long-term amiodarone therapyQ67233122
High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in plasma or serum at the concentrations attained following a single 400-mg doseQ70483377
An appreciation of hypertrophic cardiomyopathyQ70649310
Amiodarone pharmacokineticsQ71019701
Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic studyQ71233565
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmiasQ71734447
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmiasQ93857521
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectamiodaroneQ410061
hypertrophic cardiomyopathyQ1364270
P304page(s)802-810
P577publication date1984-10-01
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleAmiodarone for long-term management of patients with hypertrophic cardiomyopathy
P478volume54